Higher blood levels of a marker of nerve damage are associated with lower daily activity in people with progressive forms of ...

Genentech, affiliated to Swiss drug major Roche Holding AG ( RHHBY ,RO.SW,ROG.SW) announced Wednesday that the U.S. Food and Drug Administration has accepted its New Drug Application or NDA under ...

Existing drug may slow progression of MS in ‘exciting’ world-first trial - The antioxidant and anti-inflammatory medicine, ...

Most people with multiple sclerosis (MS) are diagnosed between age 20 and 50, though it can occur in children as well as in older adults, according to the National Multiple Sclerosis Society (NMSS).

High serum glial fibrillary acidic protein levels indicate an increased risk for progression independent of relapse activity in multiple sclerosis.

Researchers have traced a previously observed link between microscopic organisms in the digestive tract—collectively known as the gut microbiome—and multiple sclerosis. Their study in genetically ...